Episode
Are You Still Recommending Aspirin for Primary Prevention? - Frankly Speaking Ep 468
- Published
- Jan 19, 2026
- Duration seconds
- 583
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/frankly-speaking-about-family-medicine-434006/episodes/are-you-still-recommending-aspirin-for-primary-prevention-frankly-speaking-ep-468/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006/are-you-still-recommending-aspirin-for-primary-prevention-frankly-speaking-ep-468.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-468 Overview: We first discussed aspirin use for primary prevention of cardiovascular disease in 2022 when the USPSTF recommended against it. In this follow-up episode, we review new trial data reinforcing that guidance and help you translate the evidence into safer prevention strategies. Build confidence in supporting patients with evidence-based approaches to reduce cardiovascular risk. Episode resource links: Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial. Eur Heart J. 2025 Aug 12:ehaf514. doi: 10.1093/eurheartj/ehaf514. Epub ahead of print. PMID: 40796244. Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at [email protected] The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.